Combination treatment for hematological and non hematological malignancies

摘要

This refers to a Therapeutic method for the treatment of malignant hematological Diseases not comprising administering anti igf-1r particularly Antibodies anti Human igf-1r to a patient, in conjunction with the Administration of at least one other Therapeutic Agent.This further relates to pharmaceutical compositions comprising these Antibodies and Methods of using these compositions for the treatment of the same.